What's breaking now, across thousands of outlets.
A joint team of researchers at Bar-Ilan University and the Weizmann Institute has used advanced computational design methods to enhance the ability of genetically engineered immune cells to recognize and attack cancer and viral targets.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
A groundbreaking brain imaging study in awake rats reveals that the psychedelic mescaline uniquely alters brain function.
Shajila Siricilla, Ph.D., assistant professor of pediatrics, and Jennifer Herington, Ph.D., associate professor of pediatrics, led a team that systematically screened 1,191 FDA-approved drugs and…
Stable employment in midlife was associated with better cognitive health later in life, according to a new study from Columbia University Mailman School of Public Health's Butler Aging Center.
Researchers at Trinity College Dublin, in collaboration with Breye Therapeutics, have found that an oral medication ("Danegaptide") can protect against vision-threatening damage in nonproliferative…
Health tech company CertifyOS is launching a new national model for provider credentialing, with several major payers already on board as participants.
OXFORD, England — The world's first therapy designed to fix a patient's unique genetic mutation cost $1.65 million to make, a key facilitator of the project revealed Wednesday at a rare disease…
